<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04758091</url>
  </required_header>
  <id_info>
    <org_study_id>2019-58-03/04</org_study_id>
    <nct_id>NCT04758091</nct_id>
  </id_info>
  <brief_title>Effect of Tourniquet Application on Optic Nerve Sheath Diameter</brief_title>
  <official_title>The Effect of Tourniquet Application on Optic Nerve Sheath Diameter and Cerebral Oxygenation During Lower Extremity Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zonguldak Bulent Ecevit University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zonguldak Bulent Ecevit University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study to investigate the effect of tourniquet application on optic nerve&#xD;
      sheath diameter (ONSD) and cerebral oxygenation during lower extremity surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 15, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>optic nerve diameter</measure>
    <time_frame>during the surgery</time_frame>
    <description>measuring the change in optic nerve diameter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>regional cerebral oxgenation</measure>
    <time_frame>during the surgery</time_frame>
    <description>measurement rSo2 by Near Infrared spectroscopy</description>
  </primary_outcome>
  <enrollment type="Actual">1</enrollment>
  <condition>Intracranial Pressure Increase</condition>
  <eligibility>
    <study_pop>
      <textblock>
        lower extremity surgery with tourniquet&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I-II risk group over the age of 18&#xD;
&#xD;
          -  Operation planned under general anesthesia&#xD;
&#xD;
          -  Lower extremity surgery with a tourniquet&#xD;
&#xD;
          -  Agreeing to volunteer for research with an informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgical procedures&#xD;
&#xD;
          -  neurological disease, carotid disease&#xD;
&#xD;
          -  Previous intracranial or ocular surgery&#xD;
&#xD;
          -  Neurological symptoms&#xD;
&#xD;
          -  cerebral edema, high IntraCranial Pressure&#xD;
&#xD;
          -  Presence of glaucoma&#xD;
&#xD;
          -  Body mass index (BMI)&gt; 35&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Diabetic retinopathy&#xD;
&#xD;
          -  anemia&#xD;
&#xD;
          -  coronary artery disease&#xD;
&#xD;
          -  peripheral artery disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zonguldak BÃ¼lent Ecevit University Medicine Faculty</name>
      <address>
        <city>Zonguldak</city>
        <state>Kozlu</state>
        <zip>67600</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zonguldak Bulent Ecevit University</investigator_affiliation>
    <investigator_full_name>Bahar Say</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>Optic Nerve Sheath Diameter</keyword>
  <keyword>Tourniquet</keyword>
  <keyword>Cerebral Oxygenation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

